Concepedia

Roberto Gomez-Casal

RG

Statistics

Publications

6

Citations

390

H-Index

6

Active since

2013

Affiliations

University of Pittsburgh(Current)

UPMC Hillman Cancer Center

Synta Pharmaceuticals (United States)

Harvard University

University of Pittsburgh Medical Center

Roberto Gomez-Casal is an author at University of Pittsburgh specializing in oncology, radiation oncology, and cell biology.

ORCID

Top concepts

Publications per year

2013–2022

6

Publications

6

Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes

Roberto Gomez-Casal, Chitralekha Bhattacharya, Nandita Ganesh et al. · Molecular Cancer · 2013 · 223 citations · Full text

TMEM16A/ANO1 Inhibits Apoptosis Via Downregulation of Bim Expression

Neal R. Godse, Nayel Khan, Zachary A. Yochum et al. · Clinical Cancer Research · 2017 · 60 citations · Full text

Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy

Avani R. Vyas, Roberto Gomez-Casal, Silvia Cruz‐Rangel et al. · Proceedings of the National Academy of Sciences · 2022 · 36 citations · Full text

, , +17

Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition

Roberto Gomez-Casal, Michael W. Epperly, Hong Wang et al. · Oncotarget · 2015 · 29 citations · Full text

, , +21

The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells

Roberto Gomez-Casal, Chitralekha Bhattacharya, Michael W. Epperly et al. · Cancers · 2015 · 21 citations · Full text

, , +17

1–5 of 6